NASDAQ: CNTG - Centogene N.V.

Altı ay boyunca karlılık: -70.32%
Sektör: Healthcare

Promosyon programı Centogene N.V.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services.

daha fazla ayrıntı
In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2019-11-07
ISIN NL0014040206
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.centogene.com
Günlük fiyat değişimi: 0% (0.1211)
Haftalık fiyat değişimi: -9.9% (0.1344)
Aylık fiyat değişimi: +34.56% (0.09)
3 ayda fiyat değişimi: -39.45% (0.2)
Altı ayda fiyat değişimi: -70.32% (0.408)
Yıllık fiyat değişimi: -89.91% (1.2)
3 yılda fiyat değişimi: -97.66% (5.17)
5 yılda fiyat değişimi: -99.07% (13.05)
10 yılda fiyat değişimi: 0% (0.1211)
Yılbaşından bu yana fiyat değişimi: +15.89% (0.1045)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0.6114 10
P/BV -1.48 0
P/E 0 0
EV/EBITDA -2.93 0
Toplam: 5

Yeterlik

İsim Anlam Seviye
ROA, % -45.07 0
ROE, % 137.55 10
Toplam: 3.33

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -2.2 10
Toplam: 9.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -2.54 0
karlılık Ebitda, % 142.23 10
karlılık EPS, % -94.96 0
Toplam: 5.6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Platinum Investment Management Ltd 2377150 8.61
Wells Fargo & Company 206389 0.75
Acadian Asset Management. LLC 24703 0.09
Blackrock Inc. 21578 0.08
Millennium Management LLC 19731 0.07
Morgan Stanley 18231 0.07
Stifel Financial Corporation 16450 0.06
Barclays PLC 15348 0.06
Geode Capital Management, LLC 11156 0.04
Meeder Asset Management, Inc. 138 0



Süpervizör İş unvanı Ödeme Doğum yılı
Ms. Kim Stratton CEO & Member of Management Board 932.62k 1962 (63 yıl)
Mr. Jose Miguel Coego Rios CFO, Legal & IT and Member of Management Board 323.87k 1974 (51 yıl)
Dr. Peter Bauer M.D. Interim MD, Chief Medical & Genomic Officer and Member of Management Board 186.31k 1970 (55 yıllar)
Dr. Andrin Oswald M.D., Ph.D. Advisor 943.45k 1972 (53 yıl)
Mr. Ian Rentsch Chief Commercial Officer & GM of Pharma N/A 1976 (49 yıllar)

Adres: Germany, Rostock, Am Strande 7 - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.centogene.com